Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
173.10
-10.80 (-5.87%)
Sep 10, 2026, 11:59 AM HKT

Duality Biotherapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
842.131,8521,9411,787
Revenue Growth
-54.52%-4.61%8.66%-
Gross Profit
-233.67589.09784.671,359
Operating Income
-1,493-460.12-187.04736.27
Net Income
-1,439-2,595-1,050-357.51
Earnings Per Share
-16.09-39.82-131.30-44.69
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
3,0363,3801,3971,136
Total Debt
379.46149.785.295.32
Net Cash (Debt)
2,6573,2301,3921,131
Net Cash Growth
-17.75%132.13%23.07%-
Net Cash Per Share
29.7149.58173.96141.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-818.88194.58285.78816.34
Capital Expenditures
-11.5-11.5-4.08-11.28
Free Cash Flow
-830.38183.08281.7805.05
Free Cash Flow Growth
--35.01%-65.01%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
-27.75%31.81%40.42%76.06%
Operating Margin
-177.24%-24.85%-9.63%41.21%
Pretax Margin
-170.82%-140.13%-52.26%-11.32%
Profit Margin
-170.82%-140.13%-54.11%-20.01%
FCF Margin
-98.61%9.89%14.51%45.06%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
P/FCF Ratio
-130.88--
PS Ratio
17.1112.94--